InvestorsHub Logo
Followers 33
Posts 1622
Boards Moderated 0
Alias Born 10/06/2015

Re: DonDonDonDon post# 169064

Friday, 06/04/2021 3:36:17 PM

Friday, June 04, 2021 3:36:17 PM

Post# of 233563
Don

Due to FDA interference and failure to conform to their own guideline of DO NO HARM, the desired "P Value" was not met.

The drug itself performed as expected

MEANING>>

LERONLIMAB PERFORMED QUITE WELL AND SAVED PEOPLE.

SO
AS I'M SURE YOU, DON DON DON DON, AGREE

Leronlimab has no Severe Adverse Effects
Leronlimab has SAVED MANY LIVES

AND THOSE ARE SUCCESSES IN ANYBODY'S BOOK!


Now the failure, IMHO, belongs to the FDA who by disallowing doses 3 and 4 of the safe, lifesaving drug leronlimab, in essence allowed some subjects to die.

I guess "do no harm" isn't relevant anymore?


Don, what do YOU think about the FDA keeping those life saving does of leronlimab from Critical folks in the Covid19 trial C12?

Were you appalled, shocked. Alarmed or what?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News